MCCAIG/iStock via Getty Images Investment Overview Eli Lilly and Company (NYSE:LLY), the world's most valuable pharmaceutical company by market cap, announced its Q2 2024 earnings on Thursday last week. Let's begin by reviewing the headline figures. Revenues grew by 36% year-on-year, to $11.3bn. On a GAAP basis, operating expenses grew 14$5.42bn, and operating income was $3.72bn - up 90$2.97bn, up 86% year-on-year, while earnings per share ("EPS") came to $3.28. On a non ...